PE firm merges three companies to form AleraCare

Tuesday, May 14, 2019

LOS ANGELES – St. Cloud Capital, a private equity firm based here, has announced a growth capital investment in AleraCare Holdings, a provider of home and community based healthcare and pharmacy services. AleraCare now comprises three companies: MedicoRx Specialty Pharmacy, a specialty and home infusion pharmacy serving the California market; Vasco Infusion, a physician healthcare practice with several ambulatory infusion centers serving the Arizona and northern California markets; and VascoRx Specialty Pharmacy, a specialty and compounding pharmacy holding licenses in 50 states. As AleraCare, these companies will provide a full spectrum of specialty pharmaceutical services to its current managed care partners, manufacturers, patients and physicians, as well as increase its presence and provide greater access to its services throughout the western U.S., the company says. “This merger will strengthen our position as a healthcare services provider,” said Russ Corvese, CEO of AleraCare. “The combination of the strengths of individual companies will create a leading physician healthcare and specialty pharmacy practice providing our patients and partners an unparalleled access to care, lowers costs and improved outcomes.” St. Cloud’s investment, in conjunction with a new ABL facility, was used to refinance existing senior debt, as well as fund numerous capital investment initiatives.